Product
TN-201
1 clinical trial
1 indication
Indication
Hypertrophic CardiomyopathyClinical trial
First-in-Human, Open-Label, Safety, Tolerability, Dose-Finding, Pharmacodynamic and Cardiac Transgene Expression Study of TN-201, a Recombinant Adenoassociated Virus Serotype 9 (AAV9) Containing Myosin Binding Protein C Transgene, in Adults With MYBPC3 Mutation-Associated Hypertrophic Cardiomyopathy (HCM)Status: Recruiting, Estimated PCD: 2025-12-01